Connect With Us

Inside INdiana Business
Subscribe Now Log In
  • Home
  • News
    • Education
    • Health
    • Tech
    • STEM
    • Advanced Manufacturing & Logistics
    • Life Sciences
    • Ag INnovation
    • INPower
  • Videos
  • Big Wigs
    • Submit Big Wigs
  • Events
    • Engage Southwest Indiana – Evansville
    • Engage Northwest Indiana – Valparaiso
    • Engage Greater Lafayette – West Lafayette
    • Engage West Central Indiana – Terre Haute
    • Engage South Bend – Elkhart
    • Engage Northeast Indiana – Fort Wayne
    • Engage Central Indiana – Indianapolis
  • Newsletters
  • Podcasts
  • On-Air
    • TV & Radio Listings
  • Contact
    • About IIB
    • Meet the Team
    • Contact Us
    • Advertise
    • Gift Cards
    • Flagship Stations
    • Gerry’s Message
    • Speaking Engagement Request

Connect With Us

Lilly Announces $8B Acquisition

Monday, January 7, 2019 08:49 AM EDT Updated: Monday, January 7, 2019 09:18 AM EDT
By Andy Ober
Lilly Announces $8B Acquisition Lilly last month detailed plans to invest $850 million into its U.S. operations this year.

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced an $8 billion deal to acquire Loxo Oncology in Connecticut. Lilly says the deal adds precision medicines to its oncology portfolio through Loxo’s pipeline of medicines for patients with certain types of cancers.

The Indy drugmaker says the acquisition would be the largest in its ongoing effort to strengthen its cancer treatment portfolio. Loxo’s pipeline is focused on cancers that involve single gene abnormalities that can be detected by genomic testing. The company says targeted medicines, like those in Loxo’s portfolio, can often treat those cancers with "dramatic effect."

Loxo’s investigational medicines include LOXO-292, which has been granted Breakthrough Therapy designation from the U.S. Food and Drug Administration. The company says the treatment, which targets certain lung and thyroid cancers, among others, could launch in 2020.

Lilly Oncology President Anne White says the acquisition represents an "exciting and immediate" opportunity to expand Lilly’s portfolio, adding the Indy company is looking forward to advancing the "pioneering scientific innovation begun by Loxo Oncology."

Story Continues Below

Most Popular Stories

  • Indy to host 2025 Global Entrepreneurship Congress

  • 3 Floyds planning to reopen Munster brewpub

  • 11 Indiana schools recognized with 2023 National Blue Ribbon

  • AgriNovus launches next Innovation Challenge

  • Fort Wayne begins work on next Riverfront project

  • Proud to have a new gas meter

Perspectives

Proud to have a new gas meter

Proud to have a new gas meter

No, you didn’t read it wrong. Nor was the headline a rare typo by the nimble Inside INdiana Business crew. I have a new gas meter … and I’m kind of proud....

Inside INdiana Business

Inside INdiana Business
A division of IBJ Media

1 Monument Circle, Suite 300
Indianapolis, IN 46204

PHONE: (317) 634-6200

FAX: (317) 263-5060

NEWSLETTER@IIBNEWS.COM

  • Home
  • News
  • Videos
  • Gerry Dick
  • Newsletters
  • On-Air
  • Contact

Copyright © 2023 All Rights Reserved Privacy Policy | Terms of Service